SFX by Ex Libris Inc.

Title:	Permeability assessment of the focused ultrasound-induced blood–brain barrier opening using dynamic contrast-enhanced MRI
Source:	Physics in Medicine and Biology [0031-9155] Vlachos, F yr:2010

Basic

Full text

Full text available via EZB-NALIM-00482 IOP Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gupta, R. K. K. "T1-Weighted Dynamic Contrast-Enhanced MR Evaluation of Different Stages of Neurocysticercosis and Its Relationship with Serum MMP-9 Expression." AJNR, American journal of neuroradiology 34.5 (2013): 997-1003.
description	2.	Irwan, Y. "Quantitative analysis of cytokine-induced vascular toxicity and vascular leak in the mouse brain." Journal of immunological methods 349.1-2 (2009): 45-55.
description	3.	Liu, H. "Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain." Proceedings of the National Academy of Sciences of the United States of America 107.34 (2010): 15205-15210.
description	4.	Dash, Alekha K K. "Separation methods that are capable of revealing blood-brain barrier permeability." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 797.1-2 (2003): 241-254.
description	5.	Reinvang, I. "APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease." Neuroscience & biobehavioral reviews 37.8 (2013): 1322-1335.
description	6.	Pike, M M. "High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI." Magnetic resonance in medicine 61.3 (2009): 615-625.
description	7.	Jordo, Jessica F. "Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease." PloS one 5.5 (2010).
description	8.	SuchÃ½, M. "Synthesis of MRI contrast agents derived from DOTAM-Gly-l-Phe-OH incorporating a disulfide bridge : Conjugation to a cell penetrating peptide and preparation of a dimeric agent." Bioorganic & medicinal chemistry letters 20.18 (2010): 5521-6.
description	9.	Liu, H. "Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment." Radiology 255.2 (2010): 415-425.
description	10.	Yang, H. "NOVEL MAGNETIC/ULTRASOUND-FOCUSING SYSTEM ENHANCES NANOPARTICLE DRUG DELIVERY FOR GLIOMA TREATMENT." Neuro-oncology 11.5 (2009): 592-592.
description	11.	Madsen, Steen J. "Site-specific opening of the blood-brain barrier." Journal of Biophotonics 3.5-6 (2010): 356-367.
description	12.	Pagliara, A. "Evaluation and prediction of drug permeation." Journal of Pharmacy and Pharmacology 51.12 (1999): 1339-1357.
description	13.	Lazaro, E. "Characterization of the acidity of residual silanol groups in immobilized artificial membranes." Journal of chromatography 1182.2 (2008): 233-236.
description	14.	Österberg, T.. "Prediction of drug transport processes using simple parameters and PLS statistics - The use of ACD/logP and ACD/ChemSketch descriptors." European journal of pharmaceutical sciences 12.3 (2000): 327-337.
description	15.	Ohtsuki, S. "New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system." Biological & pharmaceutical bulletin 27.10 (2004): 1489-96.
description	16.	Elmquist, W F F. "Application of microdialysis in pharmacokinetic studies." Pharmaceutical Research 14.3 (1997): 267-88.
description	17.	Choi, J. "A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging." Angewandte Chemie (International ed.) 47.33 (2008): 6259-6262.
description	18.	Goldberg, Daniel R E. "Genes and the parsing of cognitive processes." Trends in cognitive sciences 8.7 (2004): 325-35.
description	19.	Ingallinella, P. "A new method for chemoselective conjugation of unprotected peptides to dauno- and doxorubicin." Bioorganic & medicinal chemistry letters 11.10 (2001): 1343-1346.
description	20.	"Amyloid-[beta] plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound." Experimental neurology 248 (2013): 16-.